Cardiovascular

Clinicians, researchers, and payer experts convened in Aurora, Colorado, on August 13, 2024, for discussions on ensuring that the recent advancements in lipid management are making their way to patients.

Spouses and first-degree relatives of patients with genitourinary (GU) cancers face increased risks of developing cardiovascular and psychological comorbidities, particularly within the first year of diagnosis.

Ty J. Gluckman, MD, FACC, FAHA, of Providence St. Joseph Health, emphasizes the need for better prevention of cardiovascular risks and discusses upcoming advances in glucagon-like peptide 1 (GLP-1) therapies.

Joseph Biggio, MD, system chair and service line leader for women's services and system chair for maternal fetal medicine at Ochsner Health, discusses some of the innovations to manage hypertension during pregnancy and postpartum.

Ty J. Gluckman, MD, FACC, FAHA, of Providence St. Joseph Health, reacted positively to CMS' drug price cuts under the Inflation Reduction Act, but he also expressed concerns about the potential future impact on drug innovation.

Twice-yearly inclisiran (Leqvio) monotherapy showed clinically meaningful and statistically significant LDL-C lowering in patients at low or moderate risk of atherosclerotic cardiovascular disease in the V-MONO study.

Medicare has not clearly defined what constitutes "established cardiovascular disease," leading to variability in potential patient eligibility; therefore, researchers aimed to estimate the number of Medicare beneficiaries who would become newly eligible for semaglutide under different definitions.

Martha Gulati, MD, Cedars-Sinai, discusses the topics expected to be featured at the European Society of Cardiology (ESC) Congress, including a debate she's participating in about the role of hormone replacement therapy (HRT) in primary cardiovascular disease prevention.

Patients with cardiometabolic diseases who follow an anti-inflammatory diet have better brain health and a lower risk of dementia.

Ochsner Health's Connected Maternity Online Monitoring (MOM) program has been recognized for its innovative approach in managing hypertension during pregnancy and postpartum.

A joint session with the Society for Cardiovascular Computed Tomography (SCCT) took place on the first day of the American Society for Preventive Cardiology 2024 Congress in Salt Lake City, Utah.

Martha Gulati, MD, MS, discusses the accomplishments of the American Society of Preventive Cardiology (ASPC) during her presidency and emphasizes the importance of advancing preventive cardiology.

In advance of this year’s American Society for Preventive Cardiology (ASPC) 2024 Congress on CVD Prevention, we spoke with ASPC President-Elect Michael Shapiro, DO, FASPC, about the many can't-miss sessions at this year's record-breaking event.

Researchers identify potential reductions in statin and antihypertensive therapy eligibility using Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations.

Interventions promoting adherence to the Mediterranean diet were associated with cardiometabolic biomarkers in children and adolescents, according to one study.

Patients with atrial fibrillation who use wearable devices, like Apple Watches and FitBits, report higher anxiety levels and increased health care usage than nonusers.

No significant differences in efficacy or safety of 2 aspirin doses were found between male and female patients for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD).

Patients with both diabetes and atherosclerotic cardiovascular disease (ASCVD) have about 1.5 times higher total direct health care expenditures than those without diabetes.

The American Society for Preventive Cardiology (ASPC) 2024 Congress on CVD Prevention will take place August 2-4 in Salt Lake City, Utah.

Glucagon-like peptide-1 (GLP-1) receptor agonists provide similar reductions in major adverse cardiovascular events, all-cause death, and cardiovascular-related death in patients with overweight and obesity who do not have diabetes and in patients with diabetes.

Researchers discovered a causal relationship between air pollutants and increased cardiovascular disease (CVD) risk, highlighting the need for protective measures to mitigate exposure.

The home-based care model offers a promising strategy for improving quality of care, while also reducing health care spending.

Extreme temperatures and hurricanes are strongly associated with worsening cardiovascular health, a study finds.

The low-calorie sweetener was associated with incident major adverse cardiovascular event risk, according to one study.

This study evaluated whether limited English proficiency modifies the association between cardiovascular risk factors or cardiovascular disease and outcomes in patients hospitalized with COVID-19.